Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2151709019 | Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2159464013 | Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Combination ulcer healing drugs | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Clarithromycin (substance) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing clarithromycin (medicinal product) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing lansoprazole (medicinal product) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing metronidazole (medicinal product) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Lansoprazole (substance) | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Metronidazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Lansoprazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Clarithromycin-containing product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR